Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.1 EUR | -3.94% | -0.81% | +44.55% |
Apr. 26 | Agronomics investee raises additional EUR8 million | AN |
Apr. 26 | Agronomics' Portfolio Company Raises Additional EUR8 Million for New Protein Product | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | - | - | - | 33.98 | - | - |
Enterprise Value (EV) 1 | - | - | - | 32.68 | 32.58 | 33.98 |
P/E ratio | 163 x | 35.4 x | 70.3 x | 55.5 x | 46.9 x | 43.6 x |
Yield | - | - | 2.37% | 1.64% | 1.97% | 2.13% |
Capitalization / Revenue | - | - | - | 6.8 x | 6.66 x | 6.41 x |
EV / Revenue | - | - | - | 6.54 x | 6.39 x | 6.41 x |
EV / EBITDA | - | - | - | 40.9 x | 36.2 x | 34 x |
EV / FCF | - | - | - | -6.17 x | -6.93 x | -6.8 x |
FCF Yield | - | - | - | -16.2% | -14.4% | -14.7% |
Price to Book | - | - | 1.17 x | 1.33 x | 1.09 x | - |
Nbr of stocks (in thousands) | - | - | - | 5,571 | - | - |
Reference price 2 | 8.140 | 3.890 | 4.220 | 6.100 | 6.100 | 6.100 |
Announcement Date | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 3.763 | 3.758 | 5 | 5.1 | 5.3 |
EBITDA 1 | - | 0.8001 | 0.5654 | 0.8 | 0.9 | 1 |
EBIT 1 | - | 0.768 | 0.5543 | 0.8 | 0.9 | 1 |
Operating Margin | - | 20.41% | 14.75% | 16% | 17.65% | 18.87% |
Earnings before Tax (EBT) 1 | - | 0.7393 | 0.5362 | 0.8 | 0.9 | 1 |
Net income 1 | 0.2957 | 0.5902 | 0.3621 | 0.6 | 0.7 | 0.8 |
Net margin | - | 15.68% | 9.64% | 12% | 13.73% | 15.09% |
EPS 2 | 0.0500 | 0.1100 | 0.0600 | 0.1100 | 0.1300 | 0.1400 |
Free Cash Flow 1 | - | - | - | -5.3 | -4.7 | -5 |
FCF margin | - | - | - | -106% | -92.16% | -94.34% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | - | - | 0.1000 | 0.1000 | 0.1200 | 0.1300 |
Announcement Date | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | 1.63 | 1.3 | 1.4 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | -5.3 | -4.7 | -5 |
ROE (net income / shareholders' equity) | - | - | 1.99% | 2.7% | 2.5% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 3.590 | 4.590 | 5.590 | - |
Cash Flow per Share 2 | - | - | 0.0400 | 0.0900 | 0.1200 | - |
Capex 1 | - | - | - | 5.8 | 5.4 | 5.8 |
Capex / Sales | - | - | - | 116% | 105.88% | 109.43% |
Announcement Date | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.55% | 38.61M | |
+20.18% | 38.38B | |
+1.36% | 36.11B | |
0.00% | 20.42B | |
+6.99% | 5.44B | |
+4.24% | 4.15B | |
+3.23% | 3.3B | |
+24.41% | 3.03B | |
-8.52% | 2.62B | |
+3.52% | 1.23B |
- Stock Market
- Equities
- SPRING Stock
- Financials Springvest Oyj